source
- Compass Therapeutics unveils key secondary endpoint results from pivotal biliary tract cancer trialA year after it reported a Phase 2/3 success, Compass Therapeutics on Monday revealed further results for its closely watched bispecific antibody in second-line biliary tract cancer. While the inve…Endpoints · 3mo ago↗ source
- Intellia's in vivo CRISPR therapy first to succeed in Phase 3An experimental treatment that uses CRISPR to edit genes directly inside the body has just succeeded in a Phase 3 trial — a first for the technology — putting it on track for a potential FDA approv…Endpoints · 3mo ago↗ source
- Veradermics wins at growing hair with oral Rogaine in first key test as a public companyVeradermics has succeeded in its first major test as a newly-minted public company. The biotech's form of oral Rogaine cleared the bar in a Phase 2/3 trial in men with mild-to-moderate pattern hair…